Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Robert H, Li"'
Autor:
Suveeksha, Naidu, Tiffany, Chen, Paul, Fiorilli, Robert H, Li, Nimesh, Desai, Wilson Y, Szeto, Jay, Giri, Tai, Kobayashi, Pavan, Atluri, Howard C, Herrmann
Publikováno v:
JACC: Cardiovascular Interventions. 15:120-121
Autor:
Jay Giri, Prashanth Vallabhajosyula, Roland A. Matsouaka, Vinod H. Thourani, Fenton H. McCarthy, Ajay J. Kirtane, Wilson Y. Szeto, Saif Anwaruddin, Matthew L. Williams, Howard C. Herrmann, Sreekanth Vemulapalli, Joseph E. Bavaria, Zhuokai Li, Nimesh D. Desai, Robert H. Li
Publikováno v:
The Annals of Thoracic Surgery. 105:1121-1128
The purpose of this study is to evaluate the association of tricuspid regurgitation (TR) severity with outcomes after transcatheter aortic valve replacement (TAVR).We analyzed data from 34,576 patients who underwent TAVR at 365 US hospitals from Nove
Autor:
Saif Anwaruddin, Jay Giri, Fenton H. McCarthy, Roland A. Matsouaka, Joseph E. Bavaria, Nimesh D. Desai, Sreekanth Vemulapalli, Robert H. Li, Prakash A. Patel, Taisei Kobayashi, Amanda Stebbins, Matthew C. Hyman, Wilson Y. Szeto, Prashanth Vallabhajosyula, Howard C. Herrmann
Publikováno v:
Circulation. 136:2132-2140
Background: Conscious sedation is used during transcatheter aortic valve replacement (TAVR) with limited evidence as to the safety and efficacy of this practice. Methods: The National Cardiovascular Data Registry Society of Thoracic Surgeons/American
Autor:
Nimesh D. Desai, Robert H. Li, Jay Giri, David R. Jones, Peter J. Evans, Taisei Kobayashi, Wilson Y. Szeto, Matthew Seigerman, Robin H. Wang, Howard C. Herrmann, Paul N. Fiorilli, Pavan Atluri
Publikováno v:
Journal of the American College of Cardiology. 77:907
Autor:
Jay Giri, Saif Anwaruddin, Dinesh Jagasia, Howard C. Herrmann, Jeffrey Ogbara, Zachary Fox, Nimesh D. Desai, Anoop M. Shah, Robert H. Li, Mitul B. Kadakia, Wilson Y. Szeto, Prashanth Vallabhajosyula, Joseph E. Bavaria
Publikováno v:
Catheterization and Cardiovascular Interventions. 86:888-894
Objective Transcatheter aortic valve replacement (TAVR) has emerged as an alternative to high-risk surgery in patients with comorbid conditions. The role of TAVR in patients with liver disease has not been examined. Methods We examined the procedural
Autor:
Rebecca Marcantuono, Jacob T. Gutsche, John G.T. Augoustides, Maureen Burke‐Julien, Wilson Y. Szeto, Prakash A. Patel, Elizabeth K. Walsh, Nicole Hoke, Howard C. Herrmann, Robert Stetson, Saif Anwaruddin, Stephanie Houseman, Robert H. Li, David M. Jones, Lisa Mangino – Blanchard
Publikováno v:
Catheterization and Cardiovascular Interventions. 85:648-654
Background The care pathway for patients undergoing transcatheter aortic valve replacement (TAVR), particularly in the US, was initially based on open surgical techniques and often includes general anesthesia, transesophageal echocardiographic monito
Autor:
Elizabeth K. Walsh, Prashanth Vallabhajosyula, Saif Anwarrudin, Jay Giri, Elizabeth Cichonski, Joseph E. Bavaria, Wilson Y. Szeto, Howard C. Herrmann, Nimesh D. Desai, Robert H. Li, Matthew L. Williams
Publikováno v:
Structural Heart. 3:37
Autor:
A Garvey, Rene, Dinesh, Jagasia, S Rasi, Wickramasinghe, Nimesh, Desai, Wilson, Szeto, Prashanth, Vallabhajosyula, Robert H, Li, Frank E, Silvestry, Jay, Giri, Saurabh, Jha, Howard C, Herrmann, Saif, Anwaruddin
Publikováno v:
The Journal of invasive cardiology. 28(7)
Transcatheter aortic valve replacement (TAVR) has been commercially approved in the United States for the treatment of high-risk and inoperable patients with severe symptomatic aortic stenosis. While TAVR has proven benefits with regard to survival a
Autor:
Wilson Y. Szeto, Nimesh D. Desai, Saif Anwaruddin, Robert H. Li, Jay Giri, Prashanth Vallabhajosyula, Matthew L. Williams, Chase R. Brown, Howard C. Herrmann, Joseph E. Bavaria
Publikováno v:
Journal of the American College of Cardiology. 69:1035
Background: Patients with a very low ejection fraction (EF) have been excluded from major TAVR trials. As a consequence, the safety and efficacy of TAVR in this cohort remains uncertain. In this study, patients with pre-TAVR EF≤20% were analyzed to
Autor:
Anoop M, Shah, Jeffrey, Ogbara, Howard C, Herrmann, Zachary, Fox, Mitul, Kadakia, Saif, Anwaruddin, Joseph E, Bavaria, Nimesh D, Desai, Dinesh, Jagasia, Wilson Y, Szeto, Robert H, Li, Prashanth, Vallabhajosyula, Jay, Giri
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 86(5)
Transcatheter aortic valve replacement (TAVR) has emerged as an alternative to high-risk surgery in patients with comorbid conditions. The role of TAVR in patients with liver disease has not been examined.We examined the procedural and intermediate t